June 25, 2026 Sweden
BioStock: Anders Essen-Möller on Diamyd’s darkest hour
”Times are really tough currently. Whilst I do not wish anybody to go through what we currently are experiencing, I feel the need to step in as the CEO. At least for a short while. Yes, I am an old man. But with some experience.” So writes Anders Essen-Möller in his CEO statement in Diamyd Medical’s Q3 report. It is an unusually candid letter from a founder stepping back in at the helm of a company he built, at a moment when it stands at a crossroads.
Read the article here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.